Safety evaluation of execessive consumption of proteoglycan complex 80 from salmon nasal cartilage - a randomized, double blind, placebo-controlled study - - Safety evaluation of execessive consumption of proteoglycan complex 80 from salmon nasal cartilage

KSO Corporation0 个研究点目标入组 30 人开始时间: 2017年6月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Subjects who have been continuously treated by medicine. 2.Subjects who have a history of renal, hepatic, cardiac, respiratory, endocrine, or other metabolic disease or who have been treated for those diseases. 3.Subjects who have been regularly used medicine (Including antiflatulent and laxative) 4.Subjects who cannot stop taking supplement/health food (Including Special Health Food, Foods with "Function Claims") 5.Subjects who declared having an allergy for component of test tablet 6.Subjects who have a past surgical history or a history of digestive disease which affects digestion. 7.Subjects who are pregnant, willing to be pregnant or breast feeding. 8.Subjects with a history of drug dependence or alcohol dependence or past history of drug dependence or alcohol dependence 9.Subjects who made a blood component donation or whole blood donation more than 200mL within 4 weeks before the test starts 10.Subjects who have shift work or night shift work. 11.Subjects who have been participated in any other food or medicine intake clinical trial, cosmetic and medicine application trial or participated in any other clinical trial within 1 month after consent obtain, or who is willing to participate. 12.Any who is judged as unsuitable to participate in this clinical trial through by principal investigator or sub-investigator.

发起方